NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential wrongdoing at AmerisourceBergen Corporation ("ABC" or the "Company") (NYSE: ABC). The investigation focuses on whether certain officers and directors of ABC violated their fiduciary duties to the Company by failing to ensure that ABC had adequate internal controls to prevent the diversion of controlled substances to illegitimate channels.
Request more information now by clicking here: www.faruqilaw.com/ABC.
On August 9, 2012, ABC, a prescription drug wholesaler, disclosed that it had received subpoenas from the U.S. Attorney's Office in New Jersey and the Drug Enforcement Agency ("DEA") involving the Company's processes for handling controlled substances. The subpoenas are connected to a grand jury proceeding seeking documents about ABC's program for controlling and monitoring the diversion of controlled substances into illegitimate channels. Furthermore, in June 2012, the West Virginia Attorney General filed a lawsuit against the Company alleging that ABC failed to provide effective controls and procedures to guard against the diversion of controlled substances for illegal purposes in West Virginia.Faruqi & Faruqi, LLP is a national law firm representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The firm is focused on providing exemplary legal services in complex litigation. Founded in 1995, the firm maintains its principal office in New York City, with offices in Delaware, California, Florida and Pennsylvania. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide. If you are a current ABC shareholder, and you would like to discuss your legal rights, visit www.faruqilaw.com/ABC. You can also contact us by calling Beth A. Keller toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Contact:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts